Epigral Limited (BOM:543332)

Market Cap	78.92B
Revenue (ttm)	25.05B
Net Income (ttm)	4.33B
Shares Out	n/a
EPS (ttm)	101.44
PE Ratio	18.25
Forward PE	17.58
Dividend	6.00 (0.33%)
Ex-Dividend Date	Jun 20, 2025

Volume	14,003
Average Volume	8,696
Open	1,900.15
Previous Close	1,953.95
Day's Range	1,776.40 - 1,946.05
52-Week Range	1,506.60 - 2,408.35
Beta	n/a
RSI	48.25
Earnings Date	Jul 25, 2025

About Epigral

Epigral Limited manufactures and sells chlor-alkali and related derivatives in India and internationally. The company offers chlorinated polyvinyl chloride (CPVC) resins and compounds, epichlorohydrin, chloromethanes value chain, hydrogen peroxide, caustic soda and potash, chlorine, hydrogen, chloromethanes, captive power plant (CPP), and chlorotoluene value chain, as well as operates wind-solar hybrid power plant. Its products are used in CPVC pipes and fittings, windmills, construction, paints and coatings, electronics, water treatment, agroc...

• Industry: Chemicals and Allied Products
• Founded: 2007
• Employees: 1,072
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 543332

Financial Performance

In 2024, Epigral's revenue was 25.50 billion, an increase of 32.19% compared to the previous year's 19.29 billion. Earnings were 3.58 billion, an increase of 82.62%.